Expertise in
7
conditions

Gordon W. Moran

Nottingham, ENG, GB 
Expertise in
7
conditions
Nottingham, ENG, GB 
OverviewLocationsClinical Research

Overview

Gordon Moran practices in Nottingham, United Kingdom. Mr. Moran is highly rated in 7 conditions, according to our data. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Proctitis, Small Bowel Resection, and Endoscopy.

His clinical research consists of co-authoring 104 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Nottingham, ENG, United Kingdom
Other Locations
Manchester, ENG, United Kingdom
Stoke-on-trent, ENG, United Kingdom
Telford, ENG TF13QD, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Biological
Study Drug: Vedolizumab
Study Phase: Phase 4
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2025
Intervention Type: Other
Study Drug: Aminosalicylate
Study Phase: Phase 4
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
Reduced Appetite in Crohn's Disease: Investigating the Role of the Gut Brain Pathways
Reduced Appetite in Crohn's Disease: Investigating the Role of the Gut Brain Pathways
Enrollment Status: Completed
Publish Date: April 17, 2019
Intervention Type: Other
Study Phase: Not Applicable
Reduced Intestinal Motility in Inflammatory Crohn's Disease
Reduced Intestinal Motility in Inflammatory Crohn's Disease
Enrollment Status: Completed
Publish Date: October 25, 2017
Intervention Type: Other
Study Phase: Not Applicable
Reduced Intestinal Motility in Inflammatory Crohn's Disease - Optimisation Studies in Healthy Volunteers
Reduced Intestinal Motility in Inflammatory Crohn's Disease - Optimisation Studies in Healthy Volunteers
Enrollment Status: Completed
Publish Date: January 05, 2017
Intervention Type: Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

104 Total Publications

Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study.
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study.
Journal: BMJ open
Published: November 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Moran's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile